Article

Warburg Pincus completes Lifecore offer

According to affiliates of private equity firm Warburg Pincus, a tender offer for all outstanding shares of Lifecore Biomedical Inc., a medical materials and device maker, is complete.

New York-According to affiliates of private equity firm Warburg Pincus, a tender offer for all outstanding shares of Lifecore Biomedical Inc., a medical materials and device maker, is complete.

The offer, which was worth $17 per share or about $229.5 million, concluded with about 94.2% of outstanding Lifecore shares tendered.

Investments in health care-related companies around the world add up to $6.2 billion for Warburg Pincus, according to the private equity firm, including $2.7 billion in medical device makers such as American Medical Systems, Bausch & Lomb, ev3, Kyphon, Tornier, and Wright Medical Group.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.